BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 19364570)

  • 1. Body mass index in children with Prader-Willi Syndrome during human growth hormone therapy: a real world situation.
    Dewan T; Chanoine JP
    J Pediatr; 2009 May; 154(5):777-8; author reply 779. PubMed ID: 19364570
    [No Abstract]   [Full Text] [Related]  

  • 2. Growth hormone treatment of patients with Prader-Willi syndrome. Swedish Growth Hormone Advisory Group.
    Ritzén EM; Lindgren AC; Hagenäs L; Marcus C; Müller J; Blichfeldt S
    J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():345-9. PubMed ID: 10698600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of growth hormone therapy on patients with Prader-Willi syndrome.
    Sipilä I; Sintonen H; Hietanen H; Apajasalo M; Alanne S; Viita AM; Leinonen E
    Acta Paediatr; 2010 Nov; 99(11):1712-8. PubMed ID: 20545932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone therapy for Prader-Willi syndrome: a critical appraisal.
    Allen DB; Carrel AL
    J Pediatr Endocrinol Metab; 2004 Sep; 17 Suppl 4():1297-306. PubMed ID: 15506076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone therapy in children with Prader-Willi syndrome.
    Franzese A; Romano A; Spagnuolo MI; Ruju F; Valerio G
    J Pediatr; 2006 Jun; 148(6):846; author reply 846-7. PubMed ID: 16769405
    [No Abstract]   [Full Text] [Related]  

  • 6. Growth hormone treatment completely normalizes adult height and improves body composition in Prader-Willi syndrome: experience from KIGS (Pfizer International Growth Database).
    Lindgren AC; Lindberg A
    Horm Res; 2008; 70(3):182-7. PubMed ID: 18663319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome.
    Festen DA; de Lind van Wijngaarden R; van Eekelen M; Otten BJ; Wit JM; Duivenvoorden HJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):443-51. PubMed ID: 18363884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective study of the potential benefits and adverse events during growth hormone treatment in children with Prader-Willi syndrome.
    Fillion M; Deal C; Van Vliet G
    J Pediatr; 2009 Feb; 154(2):230-3. PubMed ID: 18814886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prader-Willi syndrome. Treatment with growth hormone in 2 cases].
    Youlton R
    Rev Med Chil; 2001 Oct; 129(10):1186-90. PubMed ID: 11775347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KIGS highlights: growth hormone treatment in Prader-Willi Syndrome.
    Tauber M; Cutfield W
    Horm Res; 2007; 68 Suppl 5():48-50. PubMed ID: 18174707
    [No Abstract]   [Full Text] [Related]  

  • 11. Sudden death in growth hormone-treated children with Prader-Willi syndrome.
    Van Vliet G; Deal CL; Crock PA; Robitaille Y; Oligny LL
    J Pediatr; 2004 Jan; 144(1):129-31. PubMed ID: 14722532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between foot growth and musculoskeletal loading in children with Prader-Willi syndrome before and during growth hormone treatment.
    Eiholzer U; Meinhardt U; Gallo C; Schlumpf M; Rousson V; l'Allemand D
    J Pediatr; 2009 Feb; 154(2):225-9. PubMed ID: 18822426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GH treatment reduces total ghrelin in Prader-Willi syndrome (PWS) and may confound ghrelin studies in young PWS children.
    Hauffa BP; Petersenn S
    Clin Endocrinol (Oxf); 2009 Jul; 71(1):155-6. PubMed ID: 19178506
    [No Abstract]   [Full Text] [Related]  

  • 14. Growth hormone therapy for short stature: is the benefit worth the burden?
    Allen DB
    Pediatrics; 2006 Jul; 118(1):343-8. PubMed ID: 16818584
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapy of growth disorders.
    Ali O; Wyatt D
    Curr Opin Endocrinol Diabetes Obes; 2011 Feb; 18(1):3-8. PubMed ID: 21150587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone therapy in adults and children.
    Levy RM
    N Engl J Med; 2000 Feb; 342(5):359. PubMed ID: 10660404
    [No Abstract]   [Full Text] [Related]  

  • 17. Auxological and endocrine evolution of 28 children with Prader-Willi syndrome: effect of GH therapy in 14 children.
    Tauber M; Barbeau C; Jouret B; Pienkowski C; Malzac P; Moncla A; Rochiccioli P
    Horm Res; 2000; 53(6):279-87. PubMed ID: 11146368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone and respiratory compromise in Prader-Willi Syndrome.
    Wilson SS; Cotterill AM; Harris MA
    Arch Dis Child; 2006 Apr; 91(4):349-50. PubMed ID: 16551791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prader-Willi syndrome: medical prevention and behavioral challenges.
    Benarroch F; Hirsch HJ; Genstil L; Landau YE; Gross-Tsur V
    Child Adolesc Psychiatr Clin N Am; 2007 Jul; 16(3):695-708. PubMed ID: 17562587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Growth hormone therapy].
    Krysiak R; Okopień B; Gdula-Dymek A
    Pol Merkur Lekarski; 2007 Apr; 22(130):305-11. PubMed ID: 17684932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.